Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS) remains controversial. This report describes the initial study design, baseline characteristics, and quality of life of patients enrolled in the FSGS Clinical Trial, a large multicenter randomized st...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gipson, Debbie S., Trachtman, Howard, Kaskel, Frederick J., Radeva, Milena K., Gassman, Jennifer, Greene, Tom H., Moxey-Mims, Marva M., Hogg, Ronald J., Watkins, Sandra L., Fine, Richard N., Middleton, John P., Vehaskari, V. M., Hogan, Susan L., Vento, Suzzane, Flynn, Patti A., Powell, Leslie M., McMahan, June L., Siegel, Norman, Friedman, Aaron L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306823/
https://ncbi.nlm.nih.gov/pubmed/21178977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2010.485
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller